The effects of lead time and visual aids in TTO valuation: A study of the EQ-VT framework

European Journal of Health Economics

Volumn 14, Issue SUPPL. 1, 2013, Pages

  Luo, Nan ^a   Li, Minghui ^b   Stolk, Elly A ^c   Devlin, Nancy J ^d  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b UNIVERSITY OF MARYLAND SCHOOL OF PHARMACY   (United States)

^c ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^d OFFICE OF HEALTH ECONOMICS   (United Kingdom)

Author keywords

EQ 5D 5L; EQ VT; Time trade off

Indexed keywords

ADULT; ARTICLE; COMPUTER PROGRAM; FEMALE; HEALTH; HEALTH STATUS; HUMAN; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TIME; VISUAL AID; YOUNG ADULT;

ADULT; AUDIOVISUAL AIDS; CHINA; EDUCATIONAL STATUS; FEMALE; HEALTH STATUS; HUMANS; MALE; PILOT PROJECTS; QUALITY OF LIFE; QUESTIONNAIRES; SINGAPORE; TIME FACTORS; VALUE OF LIFE;

EID: 84893073267     PISSN: 16187598     EISSN: 16187601     Source Type: Journal    
DOI: 10.1007/s10198-013-0504-1     Document Type: Article

References (10)

1. Dolan, P.: Modeling valuations for EuroQol health states. Med. Care 35(11), 1095-1108 (1997)
2. Tilling, C., Devlin, N., Tsuchiya, A., Buckingham, K.: Protocols for time tradeoff valuations of health states worse than dead: a literature review. Med. Decis. Making 30(5), 610-619 (2010). doi:10.1177/0272989x09357475
3. Stalmeier, P.F., Busschbach, J.J., Lamers, L.M., Krabbe, P.F.: The gap effect: discontinuities of preferences around dead. Health Econ. 14(7), 679-685 (2005). doi:10.1002/hec.986
4. Robinson, A., Spencer, A.: Exploring challenges to TTO utilities: valuing states worse than dead. Health Econ. 15(4), 393-402 (2006). doi:10.1002/hec.1069
5. Devlin, N.J., Tsuchiya, A., Buckingham, K., Tilling, C.: A uniform time trade off method for states better and worse than dead: feasibility study of the 'lead time' approach. Health Econ. 20(3), 348-361 (2011). doi:10.1002/hec.1596
6. Attema, A.E., Versteegh, M.M., Oppe, M., Brouwer, W.B., Stolk, E.A.: Lead time TTO: leading to better health state valuations? Health Econ. (2012). doi:10.1002/hec.2804
7. Herdman, M., Gudex, C., Lloyd, A., Janssen, M., Kind, P., Parkin, D., Bonsel, G., Badia, X.: Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual. Life Res. 20(10), 1727-1736 (2011). doi:10.1007/s11136-011-9903-x
8. Oppe, M., Devlin, N., van Hout, B., Krabbe, P.F.M.: EuroQol Group's international protocol for the valuation of the EQ-5D-5L. In: Proceedings of the 29th EuroQol Plenary Meeting, September 13-15, 2012, The Doelen Concert and Congress Hall, Rotterdam, The Netherlands
9. Devlin, N., Buckingham, K., Shah, K., Tsuchiya, A., Tilling, C., Wilkinson, G., van Hout, B.: A comparison of alternative variants of the lead and lag time TTO. Health Econ. (2012). doi: 10.1002/hec.2819
10. Samuelsen, C.H., Augestad, L.A., Stavem, K., Kristiansen, I.S., Rand-Hendriksen, K.: Anchoring effects in the lead-time time trade-off. In: Proceedings of the 29th EuroQol Plenary Meeting, September 13-15, 2012, The Doelen Concert and Congress Hall, Rotterdam, The Netherlands